weight loss pills glp-1 agonists Foundayo and Wegovy Pills: Side Effects GLP-1 Drugs for Weight Loss:

Mounjaro (active ingredient: tirzepatide) subcutaneous injection Initial FDA Approval: 2022 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting

10.1079/bjn20061809 75 NirumandM

Allergen transparency: Good brands clearly state if the product is free from gluten, soy, dairy, and other common allergens

For weight management, Wegovy (semaglutide) and Saxenda (liraglutide) are licensed for adults with a body mass index (BMI) of 30 kg/m or greater, or 27 kg/m or greater with weight-related comorbidities

It works by slowing tyrosinase, the enzyme that triggers melanin production

Biomolecules 10 (6), 958